|
Volumn 50, Issue 10, 2010, Pages 1635-1636
|
Non-steroidal anti-inflammatory drugs (NSAIDs) for acute migraine treatment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUTALBITAL;
BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL;
CAMBIA;
DICLOFENAC POTASSIUM;
ELETRIPTAN;
ESGIC;
FLURBIPROFEN;
IBUPROFEN;
INDOMETACIN;
NAPROXEN;
NAPROXEN PLUS SUMATRIPTAN;
NONSTEROID ANTIINFLAMMATORY AGENT;
RIZATRIPTAN;
SUMATRIPTAN;
SUMATRIPTAN SUCCINATE;
TREXIMET;
TRIPTAN DERIVATIVE;
UNCLASSIFIED DRUG;
CHRONIC DAILY HEADACHE;
CLINICAL TRIAL;
DIARRHEA;
DISEASE SEVERITY;
DRUG ABSORPTION;
DRUG CONTRAINDICATION;
DRUG COST;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
DRUG SOLUBILITY;
FLUID RETENTION;
GASTROESOPHAGEAL REFLUX;
GASTROINTESTINAL DISEASE;
HEADACHE;
HEARTBURN;
HUMAN;
IRRITABLE COLON;
KIDNEY DYSFUNCTION;
LIVER DYSFUNCTION;
MIGRAINE;
PEPTIC ULCER;
PRESCRIPTION;
PRIORITY JOURNAL;
SHORT SURVEY;
SIDE EFFECT;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ACUTE DISEASE;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
DRUG THERAPY, COMBINATION;
HUMANS;
MIGRAINE DISORDERS;
TRYPTAMINES;
|
EID: 78649289847
PISSN: 00178748
EISSN: 15264610
Source Type: Journal
DOI: 10.1111/j.1526-4610.2010.01785.x Document Type: Short Survey |
Times cited : (5)
|
References (0)
|